Related Experiment Video
Updated: May 26, 2026

06:27
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Methods for analysis of amyloid-β aggregates
Kim A Bruggink1, Mareike Müller, H Bea Kuiperij
1Radboud University Nijmegen Medical Centre, Department of Neurology, Department of Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Alzheimer Centre Nijmegen, Nijmegen, The Netherlands.
Journal of Alzheimer'S Disease : JAD
|December 14, 2011
Summary
Alzheimer's disease is linked to amyloid-beta (Aβ) protein buildup. This review details techniques for studying toxic Aβ oligomers, crucial for understanding disease progression and developing treatments.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Amyloid-beta (Aβ) protein accumulation is a hallmark of Alzheimer's disease (AD).
- Neurotoxic Aβ oligomers, not fibrils, are implicated as the primary pathogenic species.
- Understanding Aβ aggregation is key to unraveling AD pathogenesis.
Purpose of the Study:
- To review and discuss techniques for characterizing Aβ species.
- To highlight methods for studying Aβ aggregation and oligomer formation.
- To provide insights into the most effective methods for Aβ analysis.
Main Methods:
- Overview of techniques for visualizing Aβ species.
- Discussion of methods for studying Aβ structure and aggregation.
- Exploration of separation and quantification techniques for Aβ forms, including immunology-based assays.
Main Results:
- Various techniques exist to characterize Aβ species and their aggregation.
- Oligomeric Aβ species are identified as particularly neurotoxic.
- A combination of methods often yields the most comprehensive data.
Conclusions:
- Effective characterization of Aβ species requires diverse analytical techniques.
- Studying Aβ oligomers is critical for understanding Alzheimer's disease.
- Integrated approaches enhance the understanding of Aβ aggregation and its role in AD.
